Lucid Diligence Brief: OSE Immunotherapeutics refocus on lusvertikimab and Tedopi
Lucid Diligence Brief: OSE Immunotherapeutics refocus on lusvertikimab and…
Immunology Video Recap—February 25, 2026
This biweekly Immunology video recap highlights key developments across…
Immunology Today—February 25, 2026
This week's Immunology update summarizes covering clinical-trial readouts and…
ECCO 2026 Preview: Key Crohn’s and Colitis Highlights to Watch
ECCO 2026 at a Glance Get ready for ECCO 2026. LucidQuest’s preview brings…
Immunology Today—February 18, 2026
This week's Immunology update summarizes key developments in clinical trials,…
Health Mobile Apps Landscape in H2 2025
Trending in Health Mobile Apps: Current Trends, Rankings and Insights from H2…
Immunology Video Recap—February 11, 2026
This biweekly Immunology video recap summarizes key regulatory actions,…
Immunology Today—February 11, 2026
This weekly Immunology update covers regulatory actions, clinical progress,…
Immunology Today—January 28, 2026
This weekly Immunology update covers late-stage clinical readouts, regulatory…
Immunology Today—January 8, 2026
This Immunology update captures a broad range of developments, including…
Immunology Video Recap—December 3, 2025
This biweekly immunology video highlights major regulatory wins, evolving…
Immunology Today—December 3, 2025
This week’s Immunology & Gastro-Dermatology update highlights regulatory…